
Epicin RD 100mg Injection
Marketer
Vhb Life Sciences Inc
Salt Composition
Epirubicin (100mg)
Overview Epicin RD 100mg Injection
Rydacin 100mg injection treats various hematological malignancies and cancers affecting the breast, stomach, lung, ovaries, and soft tissues. It also aids in preventing bladder cancer recurrence post-surgery. Administered intravenously by a healthcare professional, it's used alone or in combination chemotherapy regimens. Dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to the prescribed regimen is crucial, as incorrect usage can lead to severe adverse reactions. Therapeutic benefits may take weeks or months to manifest; discontinuation should only occur under medical guidance. This medication may reduce contraceptive efficacy; reliable birth control is advised for both partners during treatment. Common side effects include nausea, thrombocytopenia, alopecia, amenorrhea, pyrexia, and dermatological reactions. Reduced blood cell counts increase infection risk, potentially life-threatening. Regular blood tests are mandatory to monitor blood cell counts, and kidney, liver, and heart function. Prior to treatment, disclose any liver or heart conditions and a complete list of all other medications, as interactions may impact efficacy or drug metabolism. Inform your physician if you are pregnant or lactating.
Uses of Epicin RD 100mg Injection
Malignancy
Major Benefits of Epicin RD 100mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Epicin RD 100mg Injection:
- Low blood platelets
- Nausea
- Hair loss
- Absence of menstrual periods
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Weight loss
- Decreased white blood cell count (neutrophils)
- Hot flashes
- Gastrointestinal inflammation
- Rash
- Low energy
- Eye disorder
How to use Epicin RD 100mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Epicin RD 100mg Injection works:
The anti-neoplastic agent, Epicin RD 100mg Injection, targets breast cancer cells. Its mechanism involves topoisomerase II inhibition, disrupting DNA replication. Simultaneously, it generates cytotoxic free radicals, inducing DNA damage. This dual action restricts cancerous cell proliferation and ultimately leads to their demise.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Epicin RD 100mg Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Epicin RD 100mg Injection during pregnancy carries established risks to the fetus. Nevertheless, in exceptional, life-threatening circumstances, a physician might deem its use justified if the potential advantages outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Epicin RD 100mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administration of Epicin RD 100mg Injection may induce adverse reactions that compromise driving capabilities. Nausea and vomiting, potential side effects of Epicin RD 100mg Injection, can temporarily hinder safe driving.
KidneySAFE IF PRESCRIBED
The use of Epicin RD 100mg Injection in individuals with kidney impairment is likely safe. Existing evidence indicates dose modification might be unnecessary; however, a physician's consultation is recommended. For patients exhibiting serum creatinine exceeding 5 mg/dL, reduced dosages could be explored.
LiverCAUTION
Administering Epicin RD 100mg Injection requires careful consideration in individuals with hepatic impairment. Dosage modification may be necessary. Physician consultation is advised. Epicin RD 100mg Injection is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Epicin RD 100mg Injection :
NA
Facts to Know About Epicin RD 100mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Anthracycline Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | Cytotoxic alkaloids |
